ProCE Banner Activity

Defining Alzheimer’s Disease and MCI Management in the Modern Era

Podcast Episodes

Expert faculty discuss how to best approach Alzheimer’s disease and mild cognitive impairment in clinical practice, including accurately diagnosing patients and optimizing treatment in terms of patient preferences and reimbursement options.

Released: October 31, 2023

Share

Faculty

Richard Isaacson

Richard Isaacson, MD

Director of the Institute for Neurodegenerative Diseases
Florida

Marwan Sabbagh

Marwan Sabbagh, MD, FAAN

Professor of Neurology
Alzheimer s and Memory Disorders Division
Department of Neurology
Barrow Neurological Institute
Phoenix, Arizona

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Eisai.

Eisai

Faculty Disclosure

Primary Author

Richard Isaacson, MD

Director of the Institute for Neurodegenerative Diseases
Florida

Marwan Sabbagh, MD, FAAN

Professor of Neurology
Alzheimer s and Memory Disorders Division
Department of Neurology
Barrow Neurological Institute
Phoenix, Arizona

Marwan Sabbagh, MD: consultant/advisor/speaker: Anavex, Corium, Eisai, Genentech/Roche, Lilly, Neurotherapia, NovoNordisk, Prothena, Synaptogenix, T3D; ownership interest (stocks/stock options): Alzheon, Athira, CervoMed